(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

PRESENTIA NIPD GENETICS HEREDITARY CANCER

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

PRESENTIA NIPD GENETICS HEREDITARY CANCER

ST13

US500000079279811

Classe

1, 42, 44

Pedido

79279811

Registro

6160909

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

37

Atualização mais recente

30/09/2025

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

1, 42, 44

Data de depósito

23/12/2019

Data de registro

29/09/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

29/09/2020

Última transação

30/09/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

5

Tipo de titular

99

Localização do titular

CY

Examinador

MANGUBAT,ALEXANDER GEORGE

Unidade examinadora

N30

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of three lines of stylized wording. The first line is "NIPD GENETICS" in gray in stylized form. The second line is "PRESENTIA" in stylized form, where "PRE" is in yellow, and "SENTIA" is in gray. The third line is "HEREDITARY CANCER" in yellow.

Titulares e representantes

Titulares

MEDICOVER PUBLIC CO LTD
NIPD Genetics Public Company Limited

Representantes

Paulo A. de Almeida Patel & Almeida PC

Classificação técnica

Classes Nice

Classe 1Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Kits and reagents for genetic testing for medical and scientific research purposes in the field of cancer detection; kits and reagents for cancer testing for medical and scientific research purposes; nucleic acid based kits and reagents for testing cancer diseases for medical and scientific research purposes

Classe 42

Medical laboratory services for testing of cancer and cancer prevention; design and development of medical diagnostic tests and products; medical and scientific research in the field of genetic testing; providing medical and scientific research information in the field of genetic testing; genetic testing for scientific research and analysis purposes in the field of cancer detection; genetic engineering servicesscientific research in the field of genetic engineering; scientificlaboratoryclinicalmedicaltechnological research and analysis services in the fields of nucleic acid analysiscancer testinggenetics; scientific research for medical purposes in the field of cancerous diseases

Classe 44

Medical analysis services for the diagnosis and prognosis of cancer; medical genetic testing services for diagnosisprevention and treatment of cancer; medical testing of blood for diagnosis of cancer; genetic testing and genetic counseling in the field of cancer detection; medical and health services relating to DNA and genetics testing; RNA and DNA analysis for cancer diagnosis and prognosis

Publicações

Histórico de despachos e eventos da marca no USPTO.

37 publicações encontradas

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

29/09/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

16/01/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

14/06/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

14/06/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

14/06/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

02/12/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

29/10/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

23/09/2022

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

23/09/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

23/09/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

23/09/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

20/02/2021

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

15/01/2021

XXCR

GENERIC MADRID TRANSACTION CREATED

15/01/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

29/12/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

29/09/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

14/07/2020

PUBO

PUBLISHED FOR OPPOSITION

14/07/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

24/06/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/06/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

30/05/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

29/05/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

29/05/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

26/05/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

26/05/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

26/05/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

26/05/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

26/05/2020

RFNT

REFUSAL PROCESSED BY IB

24/04/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/04/2020

RFRR

REFUSAL PROCESSED BY MPU

08/04/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

20/03/2020

CNRT

NON-FINAL ACTION WRITTEN

19/03/2020

DOCK

ASSIGNED TO EXAMINER

19/03/2020

MAFR

APPLICATION FILING RECEIPT MAILED

06/03/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/03/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

27/02/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace PRESENTIA NIPD GENETICS HEREDITARY CANCER ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.